333D Limited (ASX:T3D) Appoints John Conidi as CEO and Managing Director
Appointment of CEO & Managing Director
333D Limited announced the appointment of existing director Mr John Conidi as Chief Executive Officer and Managing Director, effective from 1 March 2025. The services agreement has no fixed term and may be terminated with a 90-day written notice. Mr Conidi will receive an annual remuneration of $240,000, subject to annual review, in addition to director fees of $30,000.
Financial Performance
Over the last 12 months, the Company has seen a substantial increase in revenue from its medical digital asset strategy.
Future Outlook
With increased investments in R&D to automate processes, 333D Limited anticipates a spike in radiology presentations due to the government’s commitment to raise GP bulk billing rates, benefiting the Company and its partners.
Motley Fool contributor Kiarra Jackson has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.